A silaproline‐containing dipeptide

The silaproline‐containing dipeptide N‐(3,3‐di­methyl‐1‐pivaloyl‐1‐aza‐3‐sila‐5‐cyclo­pentyl­carbonyl)‐l ‐alanine iso­propyl­amide, C₁₇H₃₃N₃O₃Si, has two independent molecules in the asymmetric unit and each adopts a β‐II folded conformation, where the amide on the terminal C interacts intramolecularly with the pivaloyl O atom. The five‐membered silaproline ring is C^β‐puckered, an infrequent conformation for the homol­ogous proline ring.     

N‐(l‐2‐Aminobutyryl)‐l‐alanine and 2‐(l‐alanylamino)‐l‐butyric acid 0.33‐hydrate

The crystal structure of N‐(l ‐2‐amino­butyryl)‐l ‐alanine, C₇H₁₄N₂O₃, is closely related to the structure of l ‐alanyl‐l ‐alanine, both being tetragonal, while the retro‐analogue 2‐(l ‐alanyl­amino)‐l ‐butyric acid 0.33‐hydrate, C₇H₁₄N₂O₃·­0.33H₂O, forms a new type of molecular columnar structure with three peptide mol­ecules in the asymmetric unit.     

l‐Argininamidium bis­(hydrogen­squarate)

Cations and anions of the title compound {systematic name: 1‐[4‐(amino­carbonyl)butyl]guanidinium bis­(hydrogen­squarate)}, C₆H₁₇N₅O²⁺·2C₄HO₄⁻, are connected into a three‐dimensional network by inter­molecular N—H⋯O hydrogen bonds between the l ‐argininamidium ammonium, amide and guanidinium functions and the hydrogensquarate carbonyl O atoms. The independent hydrogensquarate monoanions are linked into dimers by pairs of O—H⋯O′ hydrogen bonds.     

Hydrogen‐bonded complexes of 2‐pyridone with centrosymmetric and non‐centrosymmetric dicarboxylic acids

2‐Pyridone (2‐oxo­pyrimidine) forms hydrogen‐bonded com­plexes with di­carboxyl­ic acids, the molar ratio of 2‐pyridone/di­carboxyl­ic acid being 2:1 for the complexes with oxalic acid (ethanedioic acid), 2C₅H₅NO·C₂H₂O₄, (I), and trans‐β‐hydro­muconic acid (trans‐hex‐3‐enedioic acid), 2C₅H₅NO·C₆H₈O₄, (II), and 1:1 for the complexes with trans‐glutaconic acid (trans‐pent‐2‐enedioic acid), C₅H₅NO·C₅H₆O₄, (III), and l ‐­tartaric acid (l ‐2,3‐di­hydroxy­butane­dioic acid), C₅H₅NO·C₄H₆O₆·H₂O, (IV). Common features in the hydrogen‐bonding patterns were found for the centrosymmetric and non‐centrosymmetric acids, respectively. The 2‐pyridone mol­ecule takes the lactam form in these crystals.     

cyclo(‐Cha–Oxz–d‐Val–Thz–Ile–Oxz–d‐Val–Thz‐) N,N‐di­methyl­acetamide dihydrate: a square form of cyclo­hexyl­alanine‐incorporated ascidiacycl­amide having the strongest cytotoxicity

The title compound, 1‐cyclo­hexyl­methyl‐1‐de(1‐methyl­propyl)­asci­dia­cycl­amide N,N‐di­methyl­acet­amide di­hy­drate, C₃₉H₅₆N₈O₆S₂·C₄H₉NO·2H₂O, a cyclo­hexyl­alanine‐incorporated ascidiacycl­amide analogue ([Cha]ASC), shows a square form similar to natural ASC. On the other hand, CD (circular dichroism) spectra showed [Cha]ASC to have a folded structure in solution, making it the second known analogue to show a discrepancy between its crystal and solution structures. Moreover, the cytotoxicity of [Cha]ASC (ED₅₀ = 5.6 µg ml⁻¹) was approximately two times stronger than that of natural ASC or a related phenyl­alanine‐incorporated analogue, viz. cyclo(‐Phe–Oxz–d ‐Val–Thz–Ile–Oxz–d ‐Val–Thz‐) ([Phe]ASC), and was confirmed to be associated with the square form. However, [Phe]ASC was previously shown to be folded in the crystal structure, which suggests that the difference between the aromatic and aliphatic rings affects the molecular folding of the ASC mol­ecule.     

Conformation and structure of bis­(glycyl‐l‐aspartic acid) oxalate 0.4‐hydrate

The title bis­(glycyl‐l ‐aspartic acid) oxalate complex {systematic name: bis­[2‐(2‐ammonio­acetamido)butane­dioic acid] oxalate 0.4‐hydrate}, 2C₆H₁₁N₂O₅⁺·C₂O₄²⁻·4H₂O, crystallizes in a triclinic space group with the planar peptide unit in a trans conformation. The asymmetric unit consists of two glycyl‐l ‐aspartic acid mol­ecules with positively charged amino groups and neutral carboxyl groups, and an oxalate dianion. The twist around the C—Cα bond indicates that both the peptide mol­ecules adopt extended conformations, while the twist around the N—Cα bond shows that one has a folded and the other a semi‐extended state. The present complex can be described as an inclusion compound with the dipeptide mol­ecule as the host and the oxalate anion as the guest. The usual head‐to‐tail sequence of aggregation is not observed in this complex, as is also the case with the glycyl‐l ‐aspartic acid dihydrate mol­ecule. The study of aggregation and inter­action patterns in binary systems is the first step towards understanding more complex phenomena. This further leads to results that are of general interest in bimolecular aggregation.     

Design of peptides with α,β‐de­hydro residues: pseudo‐tripeptide N‐benzyl­oxy­carbonyl–ΔLeu–l‐Ala–l‐Leu–OCH3

The title peptide N‐benzyl­oxy­carbonyl–ΔLeu–l ‐Ala–l ‐Leu–OCH₃ [methyl N‐(benzyl­oxy­carbonyl)‐α,β‐de­hydro­leucyl‐l ‐alanyl‐l ‐leucinate], C₂₄H₃₅N₃O₆, was synthesized in the solution phase. The peptide adopts a type II′β‐turn conformation which is stabilized by an intramolecular 4 1 N—H?O hydrogen bond. The crystal packing is stabilized by two intermolecular N—H?O hydrogen bonds.     

O‐Benzyl‐N‐tert‐butoxy­carbonyl‐N‐methyl‐l‐tyrosine

The crystal structure of the title compound, alternatively called 3‐[4‐(benzyl­oxy)­phenyl]‐2‐(N‐tert‐butoxy­car­bonyl‐N‐methyl­amino)­propi­onic acid, C₂₂H₂₇NO₅, has been studied in order to ex­amine the role of N‐methyl­ation as a determinant of peptide conformation. The conformation of the tert‐butoxy­carbonyl group is trans–trans. The side chain has a folded conformation and the two phenyl rings are effectively perpendicular to one another. The carboxyl­ate hydroxyl group and the urethane carbonyl group form a strong intermolecular O—H?O hydrogen bond.     

Water polymers in l‐alanyl‐l‐methionine hemihydrate

The side chains of l ‐alanyl‐l ‐me­thionine hemihydrate, C₈H₁₆N₂O₃S·0.5H₂O, form hydro­phobic columns within a three‐dimensional hydrogen‐bond network that includes extended polymers of cocrystallized water mol­ecules and C^α—H⋯S interactions.     

N‐Z‐Pro–d‐Leu using synchrotron radiation data from a very small crystal

The crystal structure of the neuroactive artificial dipeptide N‐­benzyl­oxy­carbonylprolyl‐d ‐leucine, C₁₉H₂₆N₂O₅, was solved using synchrotron radiation data collected on a very small crystal (20 × 20 × 380 μm). The mol­ecules form hydrogen‐bonded 2₁ helices. The acid carbonyl group does not participate in strong hydrogen bonds. This is interpreted as a consequence of close‐packing requirements.     

Brucine salts of l‐α‐hydr­oxy acids: brucinium hydrogen (S)‐malate penta­hydrate and anhydrous brucinium hydrogen (2R,3R)‐tartrate at 130 K

The structures of two brucinium (2,3‐dimeth­oxy‐10‐oxostrychnidinium) salts of the α‐hydr­oxy acids l ‐malic acid and l ‐tartaric acid, namely brucinium hydrogen (S)‐malate penta­hydrate, C₂₃H₂₇N₂O₄⁺·C₄H₅O₅⁻·5H₂O, (I), and anhydrous brucinium hydrogen (2R,3R)‐tartrate, C₂₃H₂₇N₂O₄⁺·C₄H₅O₆⁻,(II), have been determined at 130 K. Compound (I) has two brucinium cations, two hydrogen malate anions and ten water mol­ecules of solvation in the asymmetric unit, and forms an extensively hydrogen‐bonded three‐dimensional framework structure. In compound (II), the brucinium cations form the common undulating brucine sheet substructures, which accommodate parallel chains of head‐to‐tail hydrogen‐bonded tartrate anion species in the inter­stitial cavities.     

N‐(2‐Carboxy­benzoyl)‐l‐leucine methyl ester

The title compound (with the systematic name 2‐{[(1S)‐1‐(methoxy­carbonyl)‐3‐methyl­butyl]amino­carbonyl}benzoic acid), C₁₅H₁₉NO₅, crystallizes in the monoclinic space group P2₁, with two independent mol­ecules per asymmetric unit. The most notable difference between the two mol­ecules is in the dihedral angles between the planes of the carboxyl group and the benzene ring, which are 3.5 (3) and 25.7 (1)°. This difference may account for the fact that two competing reactions are observed in aqueous solution, namely cyclization to form the imide N‐phthaloyl­leucine and hydrolysis of N‐(2‐carboxy­benzoyl)‐l ‐leucine methyl ester to phthalic acid and leucine.     

O‐Ethyl and O‐methyl N‐(2,3,4,6‐tetra‐O‐acetyl‐β‐d‐glucopyranosyl)thiocarbamate

In both the title structures, O‐ethyl N‐(2,3,4,6‐tetra‐O‐acetyl‐β‐d ‐gluco­pyran­osyl)­thio­carbam­ate, C₁₇H₂₅NO₁₀S, and O‐methyl N‐(2,3,4,6‐tetra‐O‐acetyl‐β‐d ‐gluco­pyran­osyl)­thiocar­bam­ate, C₁₆H₂₃NO₁₀S, the hexo­pyran­osyl ring adopts the ⁴C₁ conformation. All the ring substituents are in equatorial positions. The acetoxy­methyl group is in a gauche–gauche conformation. The S atom is in a synperi­planar conformation, while the C—N—C—O linkage is antiperiplanar. N—H?O intermolecular hydrogen bonds link the mol­ecules into infinite chains and these are connected by C—H?O interactions.     

Piv‐Proψ[CH2–NH–O]Gly–NHiPr

The pseudodipeptide, (S)‐N‐iso­propyl {[N‐(pivaloyl)­pyrrol­idin‐2‐yl]­methyl­amino­oxy}acet­amide, C₁₅H₂₉N₃O₃, adopts a global extended conformation with the hydroxy­l­amine group in the g⁺/g^? structure. The C‐terminal amide NH interacts intramolecularly with the hydroxy­lamine O atom. Both NH bonds of each mol­ecule are hydrogen bonded to the C‐­terminal amide carbonyl of a neighbouring mol­ecule.     

Ammonium N‐acetyl‐l‐threoninate and methyl­ammonium N‐acetyl‐l‐threoninate

Ammonium N‐acetyl‐l ‐threoninate, NH₄⁺·C₆H₁₀NO₄^?, and methyl­ammonium N‐acetyl‐l ‐threoninate, CH₆N⁺·­C₆H₁₀NO₄^?, crystallize in the orthorhombic P2₁2₁2₁ and monoclinic P2₁ space groups, respectively. The two crystals present the same packing features consisting of infinite ribbons of screw‐related N‐acetyl‐l ‐threoninate anions linked together through pairs of hydrogen bonds. The cations interconnect neighbouring ribbons of anions involving all the nitrogen‐H atoms in three‐dimensional networks of hydrogen bonds. The hydrogen‐bond patterns include asymmetric `three‐centred' systems. In both structures, the Thr side chain is in the favoured (g^?g⁺) conformation.     

The conversion of a pyrrole trimer derivative into a 4,5,6,7‐tetra­hydro‐4‐­(pyrrol‐2‐yl)indol‐7‐yl­tosyl­aminoindole

Vilsmeier formyl­ation of trans‐1‐(4‐methyl­phenyl­sulfonyl)‐2,5‐bis(pyrrol‐2‐yl)­pyrrolidine leads to cleavage of the central ring then a reclosure resulting in the formation of trans‐N‐[2‐formyl‐4‐(5‐formyl­pyrrol‐2‐yl)‐4,5,6,7‐tetra­hydro­indol‐7‐yl]­toluene­sulfon­amide, C₂₁H₂₁N₃O₄S.     

l‐Isoleucyl‐l‐serine 0.33‐hydrate,l‐phenyl­alanyl‐l‐serine and l‐methionyl‐l‐serine 0.34‐hydrate

The structures of the title dipeptides, C₉H₁₈N₂O₄·0.33H₂O, C₁₂H₁₆N₂O₄ and C₈H₁₆N₂O₄S·0.34H₂O, complete a series of investigations focused on l ‐Xaa‐l ‐serine peptides, where Xaa is a hydro­phobic residue. All three structures are divided into hydro­philic and hydro­phobic layers. The hydro­philic layers are thin for l ‐phenyl­alanyl‐l ‐serine, rendered possible by an unusual peptide conformation, and thick for l ‐isoleucyl‐l ‐serine and l ‐methionyl‐l ‐serine, which include cocrystallized water mol­ecules on the twofold axes.     

trans‐(dl‐Isoleucinato‐N,O)[tris(2‐aminoethyl)amine‐κ4N]cobalt(III) diperchlorate

The racemic title compound, trans‐[N,N‐bis(2‐amino­ethyl)‐1,2‐ethanediamine‐κ⁴N]­(dl ‐isoleucinato‐N,O)­cobalt(III) di­per­chlor­ate, [Co(C₆H₁₈N₄)(C₆H₁₂NO₂)](ClO₄)₂, crystallizes in the enantiomorphous space group P2₁2₁2₁ with Z = 12 (Z′ = 3). Each of the three cations in the asymmetric unit represents a different chirality of the isoleucine ligand; two of them are R (or d ) and the third is the S (or l ) enantiomer. The mixture crystallizes in a so‐called unbalanced crystallization, in which the cations adopt a chiral array of composition RRS or SSR, depending on the crystal selected for data collection.     

7‐Iodo‐8‐aza‐7‐deaza‐2′‐deoxy­adenosine and 7‐bromo‐8‐aza‐7‐deaza‐2′‐deoxyadenosine

The isomorphous structures of the title molecules, 4‐amino‐1‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐3‐iodo‐1H‐pyrazolo‐[3,4‐d]pyrimidine, (I), C₁₀H₁₂IN₅O₃, and 4‐amino‐3‐bromo‐1‐(2‐deoxy‐β‐d ‐erythro‐pento­furan­osyl)‐1H‐pyrazolo[3,4‐d]­pyrimidine, (II), C₁₀H₁₂BrN₅O₃, have been determined. The sugar puckering of both compounds is C1′‐endo (^1′E). The N‐­glycosidic bond torsion angle χ¹ is in the high‐anti range [?73.2 (4)° for (I) and ?74.1 (4)° for (II)] and the crystal structure is stabilized by hydrogen bonds.     

The α‐d anomer of 5‐aza‐7‐deaza‐2′‐deoxyguanosine

In the monohydrate of 2‐amino‐8‐(2‐deoxy‐α‐d ‐erythro‐pento­furan­osyl)‐8H‐imidazo­[1,2‐a]­[1,3,5]­triazin‐4‐one, C₁₀H₁₃N₅O₄·H₂O, denoted (I) or αZ_d, the conformation of the N‐gly­cosyl­ic bond is in the high‐anti range [χ = 87.5 (3)°]. The 2′‐deoxy­ribo­furan­ose moiety adopts a C2′‐endo,C3′‐exo(^2′T_3′) sugar puckering (S‐type sugar) and the conformation at the C4′—C5′ bond is ?sc (trans).